Aprea Therapeutics, Inc.
USD0.76
-0.05 (-6.34%)
CEO
Oren Gilad
IPO Date
2019-10-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.80
Prev. Close
$0.82
Day Low
$0.76
Day High
$0.83
52W Low
$0.55
52W High
$2.22
Market Cap
$0.00B
Volume
0.12M
| 30,978 |
| $0.68 |
| 1 Apr 2026 | Peters Richard | director | P-Purchase | Acquired | 123,915 | $0.00 |
| 1 Apr 2026 | Peters Richard | director | P-Purchase | Acquired | 123,915 | $0.68 |
| 16 Mar 2026 | Gilad Oren | director, officer: President/CEO | A-Award | Acquired | 20,175 | $0.00 |
| 16 Mar 2026 | Gilad Oren | director, officer: President/CEO | A-Award | Acquired | 80,700 | $0.77 |
| 16 Mar 2026 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | A-Award | Acquired | 10,095 | $0.00 |
| 16 Mar 2026 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | A-Award | Acquired | 40,380 | $0.77 |
| 2 Feb 2026 | Gilad Oren | director, officer: President/CEO | P-Purchase | Acquired | 28,100 | $0.77 |
| 2 Feb 2026 | Gilad Oren | director, officer: President/CEO | P-Purchase | Acquired | 28,100 | $0.89 |